| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
Basil and Gerald Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, 49100 [R. K., C. R., U. A. L., A. R.], and Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv [R. K., I. H-N., E. Z., U. A. L.], Israel
The anticancer activity of the hormonal form of vitamin D,
1,25-dihydroxyvitamin D [1,25(OH)2D], is associated with
inhibition of cell cycle progression, induction of differentiation, and
apoptosis. In addition, 1,25(OH)2D3 augments
the activity of anticancer agents that induce excessive reactive oxygen
species generation in their target cells. This study aimed to
find out whether 1,25(OH)2D3, acting as a
single agent, is a prooxidant in cancer cells. The ratio between
oxidized and reduced glutathione and the oxidation-dependent
inactivation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are
considered independent markers of cellular reactive oxygen species
homeostasis and redox state. Treatment of MCF-7 breast cancer cells
with 1,25(OH)2D3 (10100 nM for
2448 h) brought about a maximal increase of 41 ± 13%
(mean ± SE) in the oxidized/reduced glutathione
ratio without affecting total glutathione levels. The in
situ activity of glutathione peroxidase and catalase were not
affected by 1,25(OH)2D3, as assessed by the
rate of H2O2 degradation by MCF-7 cell
cultures. Neither did treatment with
1,25(OH)2D3 affect the levels of glutathione
reductase or glutathione S-transferase as assayed in cell extracts. The
hormone did not affect overall glutathione consumption and efflux as
reflected in the rate of decline of total cellular glutathione after
inhibition of its synthesis by buthionine sulfoximine. The extent of
reversible oxidation-dependent inactivation of GAPDH in
situ was determined by comparing the enzyme activity before and
after reduction of cell extracts with DTT. The oxidized fraction was
0.13 ± 0.02 of total GAPDH in control cultures and
increased by 56 ± 5.3% after treatment with
1,25(OH)2D3, which did not affect the total
reduced enzyme activity. Treatment with
1,25(OH)2D3 resulted in a
40% increase in
glucose-6-phosphate dehydrogenase, the rate-limiting enzyme in the
generation of NADPH. This enzyme is induced in response to various
modes of oxidative challenge in mammalian cells. Taken together, these
findings indicate that 1,25(OH)2D3 causes an
increase in the overall cellular redox potential that could translate
into modulation of redox-sensitive enzymes and transcription factors
that regulate cell cycle progression, differentiation, and apoptosis.
This article has been cited by other articles:
![]() |
M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kodama, T. Kondo, H. Yokote, X. Jing, T. Sawada, M. Hironishi, and K. Sakaguchi Nuclear localization of glyceraldehyde-3-phosphate dehydrogenase is not involved in the initiation of apoptosis induced by 1-Methyl-4-phenyl-pyridium iodide (MPP+) Genes Cells, December 1, 2005; 10(12): 1211 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Masuda, G. Shima, T. Aiuchi, M. Horie, K. Hori, S. Nakajo, S. Kajimoto, T. Shibayama-Imazu, and K. Nakaya Involvement of Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) in Apoptosis Induced by {beta}-Hydroxyisovalerylshikonin J. Biol. Chem., October 8, 2004; 279(41): 42503 - 42515. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wu, A. Ootani, R. Iwakiri, T. Fujise, S. Tsunada, S. Toda, and K. Fujimoto Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G580 - G587. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, and G. P. Studzinski Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium Cancer Res., March 15, 2003; 63(6): 1325 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, K. Ragheb, G. Lawler, J. Sturgis, B. Rajwa, J. A. Melendez, and J. P. Robinson Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production J. Biol. Chem., February 28, 2003; 278(10): 8516 - 8525. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lin, Y. Nagai, R. Sladek, Y. Bastien, J. Ho, K. Petrecca, G. Sotiropoulou, E. P. Diamandis, T. J. Hudson, and J. H. White Expression Profiling in Squamous Carcinoma Cells Reveals Pleiotropic Effects of Vitamin D3 Analog EB1089 Signaling on Cell Proliferation, Differentiation, and Immune System Regulation Mol. Endocrinol., June 1, 2002; 16(6): 1243 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Yeh, P. J. Daschner, J. Lopaczynska, C. J. MacDonald, and H. P. Ciolino Modulation of Glucose-6-phosphate Dehydrogenase Activity and Expression Is Associated with Aryl Hydrocarbon Resistance in Vitro J. Biol. Chem., September 7, 2001; 276(37): 34708 - 34713. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |